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Abstract
The intimate mechanisms of sepsis-induced delirium are unknown.
Among the potential contributing factors, the breakdown of the
blood–brain barrier is considered a key determinant of brain
dysfunction. The complement activation is paramount to an appro-
priate activation of the central nervous system during stress. C3a
and C5a have been extensively studied and may be involved in
sepsis-induced delirium. Here we discuss the pro and con for
inhibiting C5a to attenuate brain damage during sepsis. In par-
ticular, we discuss the hypothesis that C5a increased blood–brain
barrier permeability amy ease the brain to mount an appropriate
response to sepsis. Thus, blockade of C5a may be detrimental,
resulting in an attenuated response of the stress system.
Flierl and colleagues showed recently in mice that systemic
administration of neutralising anti-C5a antibody prevented
caecal ligation and puncture-induced damage to the
blood–brain barrier (BBB) and dysfunction of the pituitary
gland [1]. These data are in line with the well-established role
of the complement anaphylatoxin C5a in brain signalling
during inflammation [2].
C5 is constitutively expressed in neuronal and non-neuronal
brain cells. Following endotoxin administration, the C5a
receptor becomes upregulated in a time-dependent manner
within the cerebral endothelium, then in microglial cells
neighbouring the endothelium and, finally, in deeper brain
parenchyma. The complement activation has been demon-
strated in numerous inflammatory and degenerative, acute
and chronic, diseases of the brain [3]. Following C5a
upregulation, microglial cells are recruited and activated to
release proinflammatory cytokines, and their phagocytosis
capacity is enhanced, and astrocytes are also activated [4].
Subsequently, C5a contributes to the activation of the stress
system. Indeed, systemic blockade of C5a reduced lipopoly-
saccharide-induced neuronal activation in the paraventricular
nuclei and amygdala [5]. Similarly, in Flierl and colleagues’
study, C5a blockade almost fully blunted the pituitary
response to caecal ligation and puncture-induced sepsis [1].
The pro side for inhibition of C5a
Adequate neuronal function requires a highly regulated extra-
cellular environment, wherein the concentrations of ions such
as sodium, potassium and calcium must be maintained within
very narrow ranges. The brain accounts for approximately
20% of oxygen consumption in humans, and is also extremely
sensitive to a wide range of chemicals that are circulating
without harm to peripheral organ systems. It is therefore
paramount that the interface between the central nervous
system and the peripheral circulatory system (that is, the
BBB) functions as a dynamic regulator of ion balance, as a
facilitator of nutrient transport, and as a barrier to potentially
harmful molecules.
Intuitively, the disruption of this barrier may flood the brain
with neurotoxic substances. Subsequently, it is commonly
thought that the breakdown of the BBB is a key causative
factor of sepsis-associated delirium [6-8]. The stimulation of
cerebrovascular endothelial cells with septic plasma induced
dissociation of tight junction proteins such as occludin from
the cytoskeletal network, and subsequently increased the
size-selective transendothelial solute flux [9].
In patients, vasogenic oedema can be demonstrated by
magnetic resonance imaging within the Wirchow–Robin
spaces, within the posterior cerebral hemispheres and, less
frequently, as diffuse white matter oedema. Various mediators
cause BBB hyperpermeability, such as bradykinin, IL-1β,
TNFα and complement [6]. Recent experiments suggest that
upregulation of C3 induced a breakdown in the BBB and
increased gliosis, increased the water content, and up-
regulated Toll-like receptor 4 with subsequent alterations in
TNF, inducible nitric oxide synthase and aquaporin 4 [10].
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Extending these findings, Flierl and colleagues were able to
prevent the damage to the BBB by systemic administration of
an anti-C5a neutralising antibody [1]. Unfortunately, they did
not look at neuronal activation or damage to confirm any
neuroprotection. Of note, interfering with complement activa-
tion either by blocking C5a or its receptor [11], or by inhibitor
of the alternative complement pathway, attenuates neuronal
death in experimental traumatic brain injury [12].
The con side of blocking C5a
To survive stress, the brain must be alerted, must identify the
stressors and must mount an appropriate response. The
limbic system, the hypothalamic–pituitary axis and the locus
coeruleus/noradrenergic system are tightly interconnected to
orchestrate homeostasis in stress. These structures are all
behind the BBB. The circulating inflammatory mediators may
reach these brain areas via the circumventricular organs that
lack a BBB or by active transport across the BBB [6].
It is also possible that specific systems are in place to open
the BBB as a normal response to severe infection. Indeed, by
increasing the BBB permeability, C5a may ease pathogen-
associated molecular pattern access to brain sensing areas
such as paraventricular and amygdala cells. Upregulation of
C5a therefore allows the stress system to mount an
appropriate response. This assumption is supported by at
least three major facts. Firstly, blockade of C5a markedly
reduced the activation of the hypothalamic–pituitary cells [5]
and decreased the corticotrophin and corticosterone levels
[1]. This effect correlated with decreased expression of
pathogen-associated molecular pattern [5] and of cytokines
[1,5]. The resulting inappropriate hypothalamic–pituitary
adrenal axis is probably detrimental in sepsis [13]. Secondly,
in patients with sepsis, magnetic resonance imaging studies
showed that increased BBB permeability is an early,
common, and transient phenomenon [8]. Patients who did
survive to sepsis recovered a normal brain. Thirdly, C5-
deficient mice or those pretreated with a C5a receptor
antagonist are unable to mount a febrile response to
intraperitoneal endotoxin challenge [14].
Furthermore, C3 is also broadly upregulated during sepsis,
and may act as a gatekeeper – protecting the brain from any
live circulating microorganisms while the BBB is rendered
permeable. Neuronal excitation involving the excitatory
glutamate receptors may be an important underlying mecha-
nism in sepsis-induced altered neurotransmission [6]. Recent
reports suggested that C5a induced neuroprotection against
glutamate-mediated apoptosis through inhibition of caspase 3
activity, through the mitogen-activated protein kinase trans-
duction pathway, and through regulation of the glutamate
receptor GluTR2 [15]. C5 blockade may therefore inhibit
select neuroprotective actions of the complement cascade,
and may possibly exacerbate neuro-excitatory mechanisms.
Future studies should investigate neuron survival in the stress
system following C5a antibodies, or C5a receptor antago-
nists or blockade of the alternative complement pathway in
experimental sepsis.
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